Imaging and Clinical Evaluation
CT, MRI, endoscopic ultrasound, or other clinical evaluation may identify an area that needs further assessment.
Pancreatic Cancer Pathology Support
Understanding Your Pancreatic Cancer Pathology Report
Get a clearer explanation of the diagnosis, tumor type, grade, invasive tumor size, nearby tissue involvement, margins, lymph nodes, lymphatic or vascular invasion, perineural invasion, treatment effect, and additional studies documented in your pancreatic pathology report.
This educational consultation explains your existing written pathology report. It does not provide a new diagnosis, written report, official document, treatment plan, or replacement for your treating clinicians.
Understand what your report documentsAnd what may still depend on surgery, imaging, laboratory testing, or other clinical information.
Board-Certified PathologistProfessional pathology-report guidance
Secure Virtual AppointmentMeet online from the comfort of home
Patient-Friendly ExplanationClear language for complex report findings
Educational SupportNot a replacement for medical advice
Understanding the Process
How a Pancreatic Cancer Diagnosis Is Established
Imaging may identify an abnormal area in or near the pancreas. Cells or tissue may then be collected for pathology examination. If surgery is performed, the resection specimen can provide additional information that was not available from the initial sample.
Cell or Tissue Sampling
Fine-needle aspiration, core biopsy, brushing, or another procedure may collect material for cytology or histology.
Pathology Diagnosis
The pathologist examines the submitted material and may report malignancy, tumor type, differentiation, and supporting studies.
Surgical Pathology Report
A Whipple procedure, distal pancreatectomy, or other resection may document tumor size, extension, margins, lymph nodes, and treatment effect.
Not every patient has every procedure. The information available depends on the specimen, the location and type of tumor, prior treatment, and stage of care.
Different Reports, Different Questions
Biopsy or Cytology Versus Pancreatic Resection Pathology
An initial cell or tissue sample may establish a diagnosis from limited material. A surgical specimen examines a larger amount of tissue and may provide a more complete pathologic assessment of the primary tumor.
Initial Diagnostic Sample
Biopsy or Cytology Report
A small sample may be obtained through endoscopic ultrasound or another image-guided or endoscopic procedure.
- Whether malignant cells or tissue are identified
- The diagnosed tumor type when the sample permits
- Degree of differentiation or grade when assessable
- Immunohistochemistry or other supporting studies
- Limitations caused by sample size, cellularity, or artifact
After Surgical Removal
Pancreatic Resection Report
A resection report examines the tumor and the submitted pancreas, nearby tissues, surgical margins, and regional lymph nodes.
- Histologic type, grade, and invasive tumor size
- Direct extension and pancreatic surface involvement
- Lymphatic or vascular and perineural invasion
- Margin status and distance to the closest margin
- Lymph-node findings, treatment effect, and pathologic categories
Inside the Report
What Your Pancreatic Pathology Report May Tell You
A pancreatic pathology report contains findings that must be understood together. The available detail depends on whether the specimen is cytology, biopsy, or a surgical resection.
A pathology finding should not be interpreted in isolation.
Tumor type, grade, invasive size, extension, margins, lymph nodes, additional studies, imaging, and clinical findings may all contribute to the wider assessment.
Diagnosis and Tumor Type
The report may identify ductal adenocarcinoma or another pancreatic tumor type. Different tumor families are classified and reported differently.
Histologic Grade
For pancreatic ductal adenocarcinoma, grade describes how closely the tumor forms glands and may be reported as well, moderately, or poorly differentiated.
Tumor Site and Size
A resection report may document the site within the pancreas and the greatest dimension of the invasive component.
Direct Extension and Surfaces
The report may describe whether tumor involves peripancreatic soft tissue, adjacent organs, vessels, or designated pancreatic surfaces.
Surgical Margins
Resection reports identify the examined margins, whether invasive carcinoma is present, and sometimes the distance to the closest margin.
Regional Lymph Nodes
The report may state how many regional lymph nodes were examined and how many contained tumor.
Lymphatic, Vascular, or Perineural Invasion
These findings describe tumor identified within lymphatic or blood vessels or tracking around nerves in the examined tissue.
Treatment Effect and Addenda
After presurgical therapy, the report may describe response in the resection specimen. Additional studies or consultations may appear later.
Need Help Understanding These Findings?
Review the terminology, key findings, specimen limitations, and pending results in your existing pancreatic pathology report during a secure virtual consultation.
pT1Invasive tumor 2 cm or smaller
pT2More than 2 cm and 4 cm or smaller
pT3More than 4 cm
pT4Selected major arterial involvement, regardless of size
Complete StageRequires wider pathologic and clinical information
Understanding Tumor Extent
How Invasive Tumor Size and Selected Anatomic Findings Relate to pT
For exocrine pancreatic carcinoma, the pathologic T category uses the size of the invasive component for pT1 through pT3. pT4 is assigned when specified major arteries are involved, regardless of tumor size.
Invasive Size Matters
The resection report may distinguish the size of invasive carcinoma from the overall size of an associated cystic or intraductal lesion.
Major Arterial Involvement
Involvement of the celiac axis, superior mesenteric artery, or common hepatic artery is categorized separately from size alone.
Stage Is Broader Than pT
Complete staging may also require lymph-node findings, evidence of distant disease, imaging, operative findings, and assessment by the treating team.
Additional Pathology Findings
Features Considered With the Wider Clinical Picture
Pancreatic resection reports may document additional features considered alongside tumor type, invasive size, margins, lymph nodes, imaging, prior treatment, and other clinical information.
Histologic Grade
For ductal adenocarcinoma, grade reflects gland formation and differentiation. It is different from tumor size, pT category, or complete stage.
Lymphatic or Vascular Invasion
This means tumor is identified within lymphatic channels or blood vessels in the examined tissue.
Perineural Invasion
This describes tumor identified around or within nerves. It is a microscopic finding and does not by itself define the complete stage.
Treatment Effect
After presurgical therapy, a resection report may describe how much viable carcinoma remains and the degree of tumor regression.
Precursor Lesions and Background Findings
The report may document PanIN, an intraductal or cystic precursor lesion, pancreatitis, treatment-related change, or other findings. Their meaning depends on the diagnosis and specimen.
Additional Laboratory Studies
Diagnostic Stains, Tumor Testing, and Separate Genetic Results
These studies answer different questions and may appear in the main report, an addendum, or a separate laboratory or genetics document.
Diagnostic Immunohistochemistry
Additional stains may support tumor classification, help distinguish tumors with overlapping appearances, or assess selected findings.
IHCMarkers
Selected Tumor Testing
Molecular, mismatch-repair, or other tumor testing may be ordered in selected settings and may be reported separately from the initial diagnosis.
TumorMolecular
Blood Markers and Germline Testing
CA 19-9 and inherited-variant testing are separate from routine tissue interpretation. Their results may be found in laboratory or genetics reports.
CA 19-9Germline
Additional studies do not determine treatment by themselves. Your care team combines pathology, stage, imaging, health history, procedures, and other clinical information. A consultation explains what is documented without recommending therapy.
Questions About Stains, Molecular Results, or Addenda?
Get a patient-friendly explanation of studies already documented in your reports and identify which findings may still be pending or reported separately.
Putting the Results Together
What Is Confirmed, Pending, or Dependent on Other Information?
A pancreatic pathology report may answer many important questions, but it may not provide the complete clinical picture on its own.
Confirmed in the Report
Documented Pathology Findings
The diagnosis, tumor type, grade, invasive size, extension, margins, lymph nodes, invasion findings, and treatment effect may be documented when the specimen allows.
May Still Be Pending
Addenda or Separate Results
Additional stains, molecular studies, germline testing, outside consultation, later surgical specimens, or other laboratory results may still be pending.
Requires Wider Context
Complete Stage and Treatment Planning
Complete staging and treatment decisions may also require imaging, operative findings, laboratory results, health history, and assessment by the treating care team.
How HONEST Pathology Helps
A Clearer Explanation of the Report You Already Have
A pathology report consultation helps you understand terminology and findings already documented, so you can approach conversations with your treating team with greater context and more focused questions.
Upload Your Report and Records
Submit the pathology report and relevant records requested for the consultation.
Meet Online With a Pathologist
Discuss the report during a private virtual appointment and ask questions about the documented findings.
Receive a Plain-Language Explanation
Better understand the terminology and prepare questions to discuss with your treating care team.
Consultation Scope
What the Consultation Includes and Excludes
A report explanation and a formal microscopic second opinion are different services. Clear boundaries help you choose the appropriate option.
The Consultation May Explain
- The documented diagnosis and pancreatic pathology terminology
- Differences between cytology, biopsy, and surgical resection reports
- Tumor type, histologic grade, and invasive tumor size
- Direct extension, surfaces, margins, and lymph nodes
- Lymphatic, vascular, or perineural invasion and treatment effect
- Additional studies, specimen limitations, and pending results
- Questions to discuss with your treating team
The Consultation Does Not Include
- A new pathology diagnosis or replacement interpretation
- A new written report or official document
- Complete staging from the pathology report alone
- Treatment prescribing or replacement of the medical care team
- Imaging interpretation, physical examination, or assessment of symptoms
- Microscopic slide review unless a separate pathology second-opinion service is ordered
Choosing the Right Service
Report Consultation or Formal Pathology Second Opinion?
The right option depends on whether you need help understanding written results or an independent review of pathology slides, tissue, or digital images.
Frequently Asked Questions
Questions About Pancreatic Cancer Pathology Reports
These answers provide general educational information. Individual reports vary according to the specimen, procedure, prior treatment, testing, and wider clinical situation.
What information is included in a pancreatic cancer pathology report?
Depending on the specimen, the report may include the diagnosis, tumor type, grade, invasive size, site, direct extension, surfaces, margins, lymphatic or vascular invasion, perineural invasion, lymph nodes, treatment effect, pathologic categories, and additional studies.
What is the difference between a pancreatic biopsy and a resection report?
A biopsy or cytology report examines a limited sample and may establish the diagnosis. A resection report examines a larger specimen and may document invasive size, extension, margins, regional lymph nodes, and treatment effect.
What does pancreatic ductal adenocarcinoma mean?
Pancreatic ductal adenocarcinoma is the most common exocrine pancreatic carcinoma. The exact diagnosis and subtype should be read from the final pathology report because other pancreatic tumors are classified differently.
Is tumor grade the same as pancreatic cancer stage?
No. Grade describes microscopic differentiation. Stage describes anatomic extent and uses information such as invasive size, selected structure involvement, regional lymph nodes, distant disease, and wider clinical findings.
What does a positive pancreatic surgical margin mean?
It means invasive carcinoma is identified at an examined surgical margin. The report may specify which margin is involved. Its clinical significance should be discussed with the treating team in the context of the full case.
What does perineural invasion mean?
Perineural invasion means tumor is identified around or within nerves in the examined tissue. It is a pathology finding considered with the tumor type, size, margins, nodes, stage, and other clinical information.
What does treatment effect mean in a pancreatic resection report?
After presurgical therapy, the pathologist may evaluate the amount of viable cancer and the degree of tumor regression in the resection specimen. This assessment is interpreted with the rest of the report and clinical record.
When is a formal pathology second opinion more appropriate?
A formal second opinion may be appropriate when findings are complex, uncertain, unexpected, or when independent examination of the original slides or tissue could provide additional value.
Clearer Answers Begin Here
Understand the Findings in Your Pancreatic Pathology Report
Meet online with a pathologist who can explain the terminology, key findings, specimen limitations, additional studies, and questions raised by your existing report.
Educational support only. This service does not replace your treating physician, gastroenterologist, surgeon, oncologist, radiologist, genetic counselor, or medical care team.
